Abstract:Retinoic acid (RA) is an embryonic morphogen used in cancer differentiation-therapy. It causes a plethora of changes in gene expression culminating in cell differentiation. We now find that amongst them, expression of the Src-family-kinase, FGR, by itself causes cell differentiation analogous to RA. The historically dominant/classical paradigm for RA mechanism of action is transcriptional activation via binding to the ligand-activated nuclear receptors, RAR/RXR. In the HL-60 human myelo-monocytic leukemia model, an actively proliferating, phenotypically immature, lineage bi-potent NCI-60 cell line, RA causes election of the myeloid lineage and phenotypic maturation with G1/0 growth inhibition. It thereby converts transformed immature proliferating tumor cells to mature growth retarded cells that bear fidelity to non-transformed mature myeloid cells. The present study finds that expression of the FGR SFK(SRC-family-kinase) alone is sufficient to induce differentiation. Akin to RA, the phenotypic conversion manifests as expression of CD38, CD11b, and ROS, as well as the p27(kip1) CDKI (cyclin-dependent-kinase-inhibitor that retards cells in G1/0) characteristic of mature myeloid cells. To pursue mechanistic insight, signaling attributes known to promote RA-induced differentiation were analyzed to see what FGR affected. RA is known to cause expression of FGR which is incorporated into and activates a putative novel cytosolic macromolecular signaling machine(signalsome) that propels differentiation. RA enhances the abundance of signalsome constituents, their associations, and their phosphorylation. The signalsome contains connected nodes that appear as a spine to which the other components are connected. The apparent nodes are RAF, LYN, FGR, SLP-76 and CBL. All of these become enriched in the nucleus after RA-treatment. NUMB and VAV appear to provide further scaffolding functions enhanced by RA. RAF in the nucleus complexes with a RARE (retinoic acid-response-element) in the promoter of the blr1 gene, which encodes a serpentine G-protein-coupled-receptor. blr1 transcriptional activation by RA depends on RAF binding. BLR1 expression is necessary to propel RA-induced differentiation, although by itself is not sufficient to cause phenotypic differentiation. Analyzing this signaling process revealed that expression of FGR mimics RA-induced enhancement of the signalsome nodes, enhancing expression of RAF and its phosphorylation, and causing BLR1 expression. Interestingly, for cd38 and blr1, FGR apparently causes expression of genes targeted by RAR/RXR even without RA. FGR thus appears to cause signaling events and phenotypic shift characteristic of RA. In sum, the data indicate that FGR is the trigger for RA-induced differentiation. Given the historical perception of FGR as a pro-proliferation, transforming-viral-oncogene, this is a surprising paradigm shift.

Intrinsic Retinoic Acid Receptor α-Cyclin-Dependent Kinase-Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells

Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation

The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells

Retinoid-Regulated FGF8f Secretion by Osteoblasts Bypasses Retinoid Stimuli to Mediate Granulocytic Differentiation of Myeloid Leukemia Cells

Retinoic Acid Induces Leukemia Cell G(1) Arrest and Transition into Differentiation by Inhibiting Cyclin-Dependent Kinase-Activating Kinase Binding and Phosphorylation of Pml/Rar Alpha

Retinoid-modulated MAT1 Ubiquitination and CAK Activity.

FGR Src Family Kinase Causes Signaling and Phenotypic Shift Mimicking Retinoic Acid-Induced Differentiation of Leukemic Cells

Protein Kinase C Delta Mediates Retinoic Acid And Phorbol Myristate Acetate-Induced Phospholipid Scramblase 1 Gene Expression: Its Role In Leukemic Cell Differentiation

Protein kinase Cδ mediates retinoic acid and phorbol myristate acetate–induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation

Lineage Restriction of the RARalpha Gene Expression in Myeloid Differentiation.

Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.

Deregulation Of Retinoic Inducible Gene - Rig-I Underlies The Pathogenesis Of Acute Promyelocytic Leukemia.

Therapeutic Discovery Retinoid-Regulated FGF 8 f Secretion by Osteoblasts Bypasses Retinoid Stimuli to Mediate Granulocytic Differentiation of Myeloid Leukemia Cells

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy

Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor Alpha (raralpha) and Oncogenic RARalpha Fusion Proteins.

Accumulation of Hypoxia-Inducible Factor-1 Alpha Protein and Its Role in the Differentiation of Myeloid Leukemic Cells Induced by All-Trans Retinoic Acid

Mechanisms Ofall-Trans Retinoic Acid-Induced Differentiation of Acute Promyelocytic Leukemia Cells

Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor Α (RAR Α ) and Oncogenic RAR Α Fusion Proteins

Retinoic acid signaling in development and differentiation commitment and its regulatory topology

All-trans-retinoic Acid and Erk1/2 Signaling Synergistically Regulate the Expression of CD300B in Human Monocytic Cells